Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



5 of Last Week's Biggest Winners

What's better than momentum? Mo' momentum.

Let's take a closer look at five of this past week's biggest scorchers.


Nov. 9

Weekly Gain

My Watchlist

BioMarin Pharmaceutical  (Nasdaq: BMRN  )




VirnetX Holding (NYSEMKT: VHC  )




Vringo (NYSEMKT: VRNG  )




Sequenom (Nasdaq: SQNM  )




Smith & Wesson (Nasdaq: SWHC  )




Source: Barron's.

BioMarin took some big steps forward as patients testing out its experimental drug did the same. In the treatment's critical phase 3 clinical trial, patients affected by Morquio A Syndrome had the ability to walk farther with the drug.

VirnetX was a stock market winner after winning in the courtroom. It was awarded a whopping $386.2 million in a patent infringement case against Apple.

Vringo is another company that came up big in its attempt to enforce its patents. Vringo's ruling against dot-com giants wasn't as lucrative as VirnetX's, but it's a welcome decision all the same.

VirnetX and Vringo may be patent trolls, but as of now they're wealthier patent trolls if they are able to collect on the damages.

Sequenom took off on a strong sales trend for its MaterniT21 test. Sequenom is handling roughly 1,700 of the tests, a blood test for pregnant women at high risk of delivering a Down syndrome baby. The trend indicates an annual run rate of 90,000 tests performed.

Shares of Smith & Wesson shot higher. Gun makers moved higher after Obama defeated Romney. It's a move that doesn't make a lot of sense. The fear is, naturally, that Obama will introduce stricter gun control laws. The move would generate a near-term run for weaponry, but what happens after that? It also bears pointing out that the stocks had a similar reaction four years ago -- and nothing materially changed.

More winners for you
It was a great week for these five stocks. If you want to get an early read on some of tomorrow's major gainers there's a special report on three companies ready to rule their industry. The report is free -- like this article -- but it won't be around forever, so click here to check it out now.

Read/Post Comments (0) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2107332, ~/Articles/ArticleHandler.aspx, 10/20/2016 4:15:27 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,162.32 -40.30 -0.22%
S&P 500 2,141.34 -2.95 -0.14%
NASD 5,241.86 -4.55 -0.09%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/20/2016 3:59 PM
BMRN $84.18 Down -0.14 -0.17%
BioMarin Pharmaceu… CAPS Rating: ***
SQNM $0.00 Down +0.00 +0.00%
Sequenom CAPS Rating: **
SWHC $26.64 Up +0.14 +0.53%
Smith and Wesson H… CAPS Rating: ****
VHC $3.28 Down -0.18 -5.07%
VirnetX Holding CAPS Rating: *
VRNG.DL $0.00 Down +0.00 +0.00%
Vringo CAPS Rating: *